News tagged ‘ColonCancer’ clear
- The vast majority of advanced colon cancer patients in a clinical trial
were not concerned about the cost of prescription drugs, according to a
study led by Dana-Farber researchers.
Tags: chemotherapy, ColonCancer
- Newly discovered gene mutations in certain non-small cell and colorectal cancers share similarities with other genetic abnormalities that are known to respond to targeted cancer treatments. This suggests that existing therapies, already approved, could be used to treat patients with these tumors.
Tags: ColonCancer, Genomics, KinaseInhibitor, LungCancer, TargetedTherapy
- A new study by Dana-Farber researchers shows aspirin therapy can extend the life of colorectal cancer patients whose tumors carry a mutation in a key gene, but has no effect on patients who lack the mutation.
Tags: ColonCancer, Genetics
- Researchers at Dana-Farber have uncovered a cancer paradox: A
family history of colon or rectal cancer doubles one's risk of the
disease — but improves the odds of survival should the cancer develop.
- Researchers found patients who engaged in moderate physical activity were 53 percent more likely to be free of colorectal cancer than those who were less physically active.
- Patients with stage III colon cancer who have undergone surgery and
chemotherapy with the goal of cure may have a higher risk of relapsing
and dying early if they follow a predominantly "Western" diet of red
meat, fatty foods, refined grains, and desserts, according to research
led by investigators at Dana-Farber Cancer Institute in Boston.
- Colorectal cancer is the second leading cause of cancer deaths in the United States. Many people have no symptoms in the early stages of the disease. Doctors are reminding people about the importance of being regularly screened to help save lives.
Tags: ColonCancer, Prevention
- A combination of chemotherapies for colon cancer decreases recurrence
for patients under 70, but not for those who are older, according to
Mayo Clinic and Dana-Farber scientists.
Tags: chemotherapy, BasicResearch, ColonCancer
- A protein biomarker may predict better chances of survival for obese patients with colorectal cancer, but it provided no prognostic value for non-obese patients, Dana-Farber researchers report.
Showing 11-20 of 22 items